1. 2019
  2. CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition

    Noeparast, A., Giron, P., Noor, A., Bahadur Shahi, R., De Brakeleer, S., Eggermont, C., Vandenplas, H., Boeckx, B., Lambrechts, D., De Grève, J. & Teugels, E., Aug 2019, In : ONCOGENE. 38, 31, p. 5933-5941 9 p.

    Research output: Contribution to journalArticleResearchpeer-review

  3. Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review

    de Filette, J. M. K., Pen, J. J., Decoster, L., Vissers, T., Bravenboer, B., Van der Auwera, B. J., Gorus, F., Roep, B. O., Aspeslagh, S., Neyns, B., Velkeniers, B. & Kharagjitsingh, A. V., 1 Jul 2019, In : European Journal of Endocrinology.

    Research output: Contribution to journalArticleResearchpeer-review

  4. Treatment of older patients with advanced non-small cell lung cancer: A challenge

    Decoster, L. & Schallier, D., Jul 2019, In : Journal of Geriatric Oncology. 10, 4, p. 528-533 6 p.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  5. The clinical characteristics of breast cancers with a familial risk in which no BRCA1/2 mutations were found are sometimes suggestive for a genetic etiology

    Joris, S., Shahi, R. B., De Brakeleer, S., Fontaine, C., Bonduelle, M-L., Ingrid, P., Teugels, E. & De Grève, J., 15 May 2019, In : Journal of molecular and genetic medicine. 13, 2

    Research output: Contribution to journalArticleResearchpeer-review

  6. xCT/Slc7a11 deletion accelerates motor recovery and improves histological outcomes following spinal cord injury in mice

    Sprimont, L., Nicaise, C., Massie, A., Bouchat, J., Gilloteaux, J., Van Bulck, M., Rooman, I., Sato, H. & Janssen, P., 2 May 2019, Front. Neurosci. Conference Abstract: 13th Nat. Congress of the Belgian Society of Neuroscience, May 24, 2019, Royal Academy Brussels. 1 p.

    Research output: Chapter in Book/Report/Conference proceedingMeeting abstract (Book)Research

  7. Poster presentation. Phase II trial of HER2-PET/CT using 68Ga-anti-HER2 VHH1 for characterization of HER2 presence in brain metastases of breast cancer patients

    Keyaerts, M., Xavier, C., Everaert, H., Vaneycken, I., Fontaine, C., Decoster, L., Vanhoeij, M., Caveliers, V. & Lahoutte, T., 1 May 2019, In : Annals of Oncology. 30, (suppl_3): iii1-iii26. 10.1093/annonc/mdz095, 85TiP.

    Research output: Contribution to journalMeeting abstract (Journal)Research

  8. xCT/Slc7a11 deletion accelerates motor recovery and improves histological outcomes follwong spinal cord injury.

    Sprimont, L., Janssen, P., Van Bulck, M., Rooman, I., Sato, H., Bouchat, J., Gilloteaux, J., Massie, A. & Nicaise, C., May 2019.

    Research output: Unpublished contribution to conferencePosterResearch

  9. Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors

    Rogiers, A. I., Boekhout, A., Schwarze, J. K., Awada, G., Blank, C. & Neyns, B., 28 Apr 2019, In : Journal of Oncology. 2019, 17 p., 5269062.

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...49 Next

ID: 25692